US2004234549A1PendingUtilityA1

Novel recombinant and mutant adenoviruses

63
Priority: Apr 9, 1999Filed: Jun 23, 2004Published: Nov 25, 2004
Est. expiryApr 9, 2019(expired)· nominal 20-yr term from priority
C12N 2710/10343C12N 15/86A61P 31/12
63
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides novel viral vectors. In one embodiment, the present invention provides mutant and recombinant bovine adenoviruses having a deletion and/or insertion of DNA in the early gene region 4 (E4). In another embodiment, the present invention provides mutant and recombinant bovine adenovirus 1 viruses having a deletion and/or insertion of DNA in the early gene region 3 (E3). The present invention also contemplates the use of the viral vectors for vaccination, gene therapy or other applications as suitable.

Claims

exact text as granted — not AI-modified
1 - 7 . (canceled)  
     
     
         8 . A mutant virus comprising a deletion of at least a portion of the E4 gene region of a bovine adenovirus.  
     
     
         9 . The mutant virus of  claim 8  which also has a foreign DNA sequence inserted into the E4 gene region.  
     
     
         10 . The mutant virus of  claim 8 , wherein at least one open reading frame of said E4 gene region of said bovine adenovirus is completely deleted.  
     
     
         11 . A recombinant virus comprising a foreign DNA sequence inserted into the E3 gene region of a bovine adenovirus 1.  
     
     
         12 . The mutant virus of  claim 11 , wherein said foreign DNA encodes a polypeptide from a virus or bacteria selected from the group consisting of bovine rotavirus, bovine coronavirus, bovine herpes virus type 1, bovine respiratory syncytial virus, bovine para influenza virus type 3 (BPI-3), bovine diarrhea virus, bovine rhinotracheitis virus, bovine parainfluenza type 3 virus,  Pasteurella haemolytica, Pasteurella multocida  and/or  Haemophilus somnus.    
     
     
         13 . The mutant virus of  claim 12 , wherein said polypeptide comprises more than ten amino acids.  
     
     
         14 . The mutant virus of  claim 12 , wherein said polypeptide is antigenic.  
     
     
         15 . The mutant virus of  claim 12 , wherein said foreign DNA sequence is under control of a promoter located upstream of said foreign DNA sequence.  
     
     
         16 . A mutant virus comprising a deletion of at least a portion of the E3 gene region of a bovine adenovirus 1.  
     
     
         17 . The mutant virus of  claim 16  which also has a foreign DNA sequence inserted into the E3 gene region.  
     
     
         18 . The mutant virus of  claim 16 , wherein at least one open reading frame of said E3 gene region of said bovine adenovirus 1 is completely deleted.  
     
     
         19 . A vaccine comprising the mutant virus of  claim 9 .  
     
     
         20 . A method of inducing an immunological response in an animal, comprising introducing the vaccine of  claim 19  to said animal.  
     
     
         21 . A vaccine comprising the mutant virus of  claim 10 .  
     
     
         22 . A method of inducing an immunological response in an animal comprising introducing the vaccine of  claim 21  to said animal.  
     
     
         23 . A vaccine comprising the mutant virus of  claim 14 .  
     
     
         24 . A method of inducing an immunological response in an animal comprising introducing the vaccine of  claim 23  to said animal.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.